Get the Stockscreener App
6.29
0.00%
0.00
After Hours:
6.17
-0.12
-1.91%
Anteris Technologies Global Corp stock is traded at $6.29, with a volume of 460.59K.
It is up +0.00% in the last 24 hours and up +1.62% over the past month.
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
See More
Previous Close:
$6.29
Open:
$6.23
24h Volume:
460.59K
Relative Volume:
0.38
Market Cap:
$611.59M
Revenue:
$1.91M
Net Income/Loss:
$-94.23M
P/E Ratio:
-2.4662
EPS:
-2.5505
Net Cash Flow:
$-79.76M
1W Performance:
+15.62%
1M Performance:
+1.62%
6M Performance:
+32.70%
1Y Performance:
+104.89%
1-Day Range:
$6.135
$6.30
1-Week Range:
$5.2837
$6.45
52-Week Range:
$2.64
$6.9494
Anteris Technologies Global Corp Stock (AVR) Company Profile
Name
Anteris Technologies Global Corp
Sector
Industry
Phone
651-493-0606
Address
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
6.29 | 611.59M | 1.91M | -94.23M | -79.76M | -2.5505 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-11-26 | Initiated | Wells Fargo | Overweight |
| Jan-08-25 | Initiated | Lake Street | Buy |
| Jan-07-25 | Initiated | Barclays | Overweight |
| Jan-07-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-07-25 | Initiated | TD Cowen | Buy |
View All
Anteris Technologies Global Corp Stock (AVR) Latest News
Anteris Grants 20,000 Unquoted RSUs Under Employee Incentive Plan - TipRanks
US Market Wrap: Will Anteris Technologies Global Corp outperform small cap indexesWeekly Stock Report & Advanced Technical Signal Analysis - baoquankhu1.vn
Block Trades: Whats the analyst consensus on Anteris Technologies Global CorpTrade Volume Report & Entry and Exit Point Strategies - baoquankhu1.vn
Revenue Check: Is Anteris Technologies Global Corp benefiting from interest rate changesStock Surge & Accurate Trade Setup Notifications - baoquankhu1.vn
Anteris Technologies Seeks Quotation of Additional CDIs on ASX - TipRanks
Anteris Technologies Global (ASX:AVR) PB Ratio : (As of Apr. 11, 2026) - GuruFocus
AVR Options Volatility — NASDAQ:AVR - TradingView — Track All Markets
AVR Options Chain — NASDAQ:AVR - TradingView — Track All Markets
Published on: 2026-04-10 23:44:28 - baoquankhu1.vn
Anteris Technologies Global Corp at Barclays Global Healthcare Conference Transcript - GuruFocus
Aug Setups: How cyclical is Anteris Technologies Global Corps revenue streamProfit Target & Daily Profit Focused Stock Screening - baoquankhu1.vn
Surprises Report: Is Anteris Technologies Global Corp a turnaround story2026 Highlights & Entry and Exit Point Strategies - baoquankhu1.vn
Anteris adjusts CDI and common stock balances through cross-market transfers - TipRanks
Anteris Technologies Global (NASDAQ:AVR) Trading Down 5.8%Should You Sell? - MarketBeat
A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market - Proactive financial news
AVR Stock Price, Quote & Chart | ANTERIS TECHNOLOGIES GLOBAL (NASDAQ:AVR) - ChartMill
Anteris Technologies Cleans Up Capital Structure as RSUs and Options Lapse - TipRanks
JPMorgan Chase & Co. Boosts Holdings in Anteris Technologies Global Corp. $AVR - MarketBeat
Levels Update: Is Anteris Technologies Global Corp a turnaround story2026 Earnings Impact & Real-Time Volume Analysis - baoquankhu1.vn
Fidelity High Income Fund's Anteris Technologies Global Corp(AVR) Holding History - GuruFocus
Investor Mood: Does Anteris Technologies Global Corp have strong EBITDA margins2026 Trading Volume Trends & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
How cyclical is Anteris Technologies Global Corps revenue streamTreasury Yields & Consistent Growth Stock Picks - baoquankhu1.vn
Anteris Technologies Global's (AVR) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald reiterates Anteris Technologies stock Overweight rating - Investing.com
Cantor Fitzgerald reiterates Anteris Technologies stock Overweight rating By Investing.com - Investing.com Canada
Dividend Watch: Is Anteris Technologies Global Corp part of any ETF2026 Investor Takeaways & Low Volatility Stock Suggestions - baoquankhu1.vn
Anteris (AVR) registers 9.10M shares; up to $40.4M if warrants exercised - Stock Titan
Trend Recap: Will Anteris Technologies Global Corp outperform small cap indexes2026 Performance Recap & Low Risk High Win Rate Picks - baoquankhu1.vn
[EFFECT] Anteris Technologies Global Corp. SEC Filing - stocktitan.net
Anteris Technologies Global (NASDAQ:AVR) Earns Overweight Rating from Analysts at Cantor Fitzgerald - Defense World
Barclays Remains a Buy on Anteris Technologies Global Corp. (AVR) - The Globe and Mail
Value Recap: Should I hold or sell Anteris Technologies Global Corp nowTrade Analysis Summary & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Anteris Technologies (AVR) Receives Overweight Rating from Canto - GuruFocus
Anteris Technologies Global (NASDAQ:AVR) Now Covered by Analysts at Cantor Fitzgerald - MarketBeat
Anteris Technologies Global CEO Touts DurAVR Redesign, Durability Claims and TAVR Market Strategy - Yahoo Finance
Wells Fargo Initiates a Buy Rating on Anteris Technologies Global Corp. (AVR) - The Globe and Mail
Anteris Issues 78,740 Unquoted RSUs Under Employee Incentive Plan - TipRanks
Anteris Technologies Global (NASDAQ:AVR) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
Wells Fargo initiates Anteris Technologies stock at Overweight - Investing.com
Wells Fargo initiates Anteris Technologies stock at Overweight By Investing.com - Investing.com India
Total non-current liabilities of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Wall Street Analysts Are Neutral on Top Healthcare Picks - The Globe and Mail
AVR: A novel TAVR valve with proven durability and clinical benefits targets major market expansion - TradingView — Track All Markets
Growth Value: Is Anteris Technologies Global Corp part of any ETF2026 Year in Review & Verified Technical Signals - baoquankhu1.vn
Highs Report: What is Anteris Technologies Global Corp.’s market position2026 Price Targets & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Should I hold or sell Anteris Technologies Global Corp now2025 Macro Impact & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Anteris Technologies (AVR) CFO awarded 78,740 RSUs vesting 2027–2029 - Stock Titan
AVR Stock Pops Pre-Market: Medtronic Backs $200M Capital Raise To Fund Key Trial - Stocktwits
Cantor Fitzgerald Upgrades Anteris Technologies Global (NASDAQ:AVR) to Strong-Buy - MarketBeat
AVR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Anteris Technologies Global Highlights DurAVR TAVR Data, PARADIGM Pivotal Trial Plans at TD Cowen Conference - MarketBeat
Anteris Technologies Global Corp Stock (AVR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.06%
1.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):